Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19
The FDA’s Sept. 22, 2021, decision to not extend boosters to the general population – at least not yet – was a direct rebuke to the Biden administration’s announcement in August that booster shots would be rolled out to all eligible Americans beginning in late September.
Fungal infections worldwide are becoming resistant to drugs and more deadly
Research data shows that risk factors include recent surgery, diabetes and broad-spectrum antibiotic and antifungal use. People who are immuno-compromised are at greater risk than those with healthy immune systems.